Bank of America’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,653
| Closed | -$885 | – | 8725 |
|
|
2024
Q4 | $885 | Sell |
1,653
-271,957
| -99% | -$189K | ﹤0.01% | 7311 |
|
|
2024
Q3 | $482K | Buy |
273,610
+198,260
| +263% | +$277K | ﹤0.01% | 5507 |
|
|
2024
Q2 | $88.2K | Sell |
75,350
-15,324
| -17% | -$38.3K | ﹤0.01% | 6304 |
|
|
2024
Q1 | $820K | Buy |
90,674
+44,951
| +98% | +$437K | ﹤0.01% | 5054 |
|
|
2023
Q4 | $497K | Sell |
45,723
-7,125
| -13% | -$53.4K | ﹤0.01% | 5497 |
|
|
2023
Q3 | $425K | Buy |
52,848
+15,540
| +42% | +$129K | ﹤0.01% | 5420 |
|
|
2023
Q2 | $405K | Sell |
37,308
-112,009
| -75% | -$959K | ﹤0.01% | 5422 |
|
|
2023
Q1 | $1.03M | Buy |
149,317
+54,516
| +58% | +$342K | ﹤0.01% | 4880 |
|
|
2022
Q4 | $377K | Buy |
94,801
+80,248
| +551% | +$394K | ﹤0.01% | 5571 |
|
|
2022
Q3 | $97K | Buy |
14,553
+2,083
| +17% | +$12.8K | ﹤0.01% | 6363 |
|
|
2022
Q2 | $60K | Sell |
12,470
-7,512
| -38% | -$45.7K | ﹤0.01% | 6748 |
|
|
2022
Q1 | $186K | Sell |
19,982
-2,952
| -13% | -$29.3K | ﹤0.01% | 6511 |
|
|
2021
Q4 | $273K | Buy |
22,934
+852
| +4% | +$9.84K | ﹤0.01% | 6315 |
|
|
2021
Q3 | $251K | Buy |
22,082
+8,599
| +64% | +$118K | ﹤0.01% | 6147 |
|
|
2021
Q2 | $242K | Sell |
13,483
-15,611
| -54% | -$251K | ﹤0.01% | 5968 |
|
|
2021
Q1 | $450K | Buy |
29,094
+16,441
| +130% | +$238K | ﹤0.01% | 5457 |
|
|
2020
Q4 | $154K | Buy |
12,653
+3,210
| +34% | +$44.7K | ﹤0.01% | 5760 |
|
|
2020
Q3 | $122K | Buy |
9,443
+4,886
| +107% | +$42.2K | ﹤0.01% | 5580 |
|
|
2020
Q2 | $47K | Buy |
4,557
+3,566
| +360% | +$32.8K | ﹤0.01% | 6008 |
|
|
2020
Q1 | $8K | Sell |
991
-2,962
| -75% | -$25.7K | ﹤0.01% | 6428 |
|
|
2019
Q4 | $34K | Sell |
3,953
-3,569
| -47% | -$20K | ﹤0.01% | 6372 |
|
|
2019
Q3 | $45K | Buy |
7,522
+452
| +6% | +$3.65K | ﹤0.01% | 6358 |
|
|
2019
Q2 | $118K | Buy |
7,070
+1,584
| +29% | +$27.5K | ﹤0.01% | 5920 |
|
|
2019
Q1 | $92K | Sell |
5,486
-1,264
| -19% | -$18.2K | ﹤0.01% | 5927 |
|
|
2018
Q4 | $77K | Buy |
6,750
+2,173
| +47% | +$44K | ﹤0.01% | 6044 |
|
|
2018
Q3 | $183K | Buy |
4,577
+2,822
| +161% | +$80.3K | ﹤0.01% | 5535 |
|
|
2018
Q2 | $49K | Buy |
1,755
+347
| +25% | +$7.69K | ﹤0.01% | 6158 |
|
|
2018
Q1 | $22K | Sell |
1,408
-420
| -23% | -$10K | ﹤0.01% | 6358 |
|
|
2017
Q4 | $60K | Buy |
+1,828
| New | +$49.3K | ﹤0.01% | 5987 |
|
|
2017
Q2 | – | Sell |
-1
| Closed | – | – | 7234 |
|
|
2017
Q1 | $0 | Buy |
+1
| New | +$5 | ﹤0.01% | 7296 |
|
|
2016
Q4 | – | Sell |
-138
| Closed | -$1K | – | 7389 |
|
|
2016
Q3 | $1K | Sell |
138
-5,165
| -97% | -$34.9K | ﹤0.01% | 6986 |
|
|
2016
Q2 | $27K | Buy |
5,303
+8
| +0.2% | +$147 | ﹤0.01% | 6125 |
|
|
2016
Q1 | $114K | Hold |
5,295
| – | – | ﹤0.01% | 5424 |
|
|
2015
Q4 | $162K | Buy |
+5,295
| New | +$155K | ﹤0.01% | 5503 |
|
|
2014
Q4 | – | Sell |
-16,767
| Closed | -$434K | – | 8036 |
|
|
2014
Q3 | $434K | Buy |
+16,767
| New | +$518K | ﹤0.01% | 4718 |
|
Bank of America's MRNS Position: Q1 2025 in Review
Bank of America sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 1,653 shares — an estimated $885 sold.
Bank of America first reported a position in MRNS in Q3 2014 and held it in 35 quarters. The position peaked at $1.03M in Q1 2023. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.
- Bank of America reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
- Bank of America sold 1,653 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $885.
- Bank of America first reported a position in Marinus Pharmaceuticals, Inc in Q3 2014 and held it in 35 quarters.
- Bank of America's Marinus Pharmaceuticals, Inc position peaked at $1.03M in Q1 2023.
- 0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.
Based on Bank of America's 13F filing for Q1 2025, filed 15 May 2025.